Blog
RSS FeedPosted by Michael Wonder on 01 Sep 2020
Coronavirus vaccine before election unlikely — Dr. Gottlieb on FDA chief’s possible fast track
31 August 2020 - The former FDA commissioner said the more effective the vaccine is, and the more serious the U.S. ...
Posted by Michael Wonder on 31 Aug 2020
A quick virus test? Sure, if you can afford it.
31 August 2020 - Standard tests in New York City can take days or weeks. Wealthier people are turning to concierge ...
Posted by Michael Wonder on 30 Aug 2020
FDA head says he is willing to fast-track COVID-19 vaccine
30 August 2020 - Stephen Hahn insists he will not rush process just to help Donald Trump’s election chances. ...
Posted by Michael Wonder on 27 Aug 2020
COVID-19 vaccines are getting closer. Should we be worried they've come so quickly?
27 August 2020 - Back in March, when the coronavirus pandemic was starting to sweep the globe, a vaccine couldn't ...
Posted by Michael Wonder on 17 Aug 2020
Clinical trials of coronavirus drugs are taking longer than expected
14 August 2020 - Antibody trials sponsored by Regeneron and Eli Lilly are off to a slow start because of a ...
Posted by Michael Wonder on 04 Aug 2020
Goldman Sachs predicts FDA will approve coronavirus vaccine this year
3 August 2020 - Goldman Sachs expects the Food and Drug Administration to approve at least one coronavirus vaccine this ...
Posted by Michael Wonder on 06 Jul 2020
Developing a SARS-CoV-2 vaccine at warp speed
6 July 2020 - The coronavirus disease 2019 (COVID-19) pandemic has unleashed major and substantial changes in the provision of health ...
Posted by Michael Wonder on 05 Jul 2020
FDA Commissioner says he can't predict when vaccine will be ready after Trump's timeline claims
5 July 2020 - Food and Drug Administration Commissioner Stephen Hahn said Sunday that he would not make a prediction ...
Posted by Michael Wonder on 15 Jun 2020
Biogen’s FDA application for Alzheimer’s drug drags on
15 June 2020 - Biogen’s filing of aducanumab, an investigational Alzheimer’s drug, for U.S. approval is drifting from its initial ...
Posted by Michael Wonder on 13 Jun 2020
Antimicrobials benefited from expedited FDA programs more than other drugs
12 June 2020 - Amid concerns over the need for more antimicrobials, a new analysis finds these medicines benefited more ...
Posted by Michael Wonder on 11 Jun 2020
U.S. FDA Commissioner says agency seeks fast review of COVID-19 products
11 June 2020 - The U.S. FDA is seeking to review treatments and tests for COVID-19 “as fast as we can” ...
Posted by Michael Wonder on 03 Jun 2020
The FDA should not rush a COVID-19 vaccine
2 June 2020 - Vaccines are widely expected to offer the best way out of the COVID-19 pandemic. ...
Posted by Michael Wonder on 03 Jun 2020
Antimicrobial approvals are not bottlenecked by FDA
3 June 2020 - Sponsors seeking US FDA approval for anti-microbial drugs accessed expedited clinical testing and review programs at least ...
Posted by Michael Wonder on 03 Jun 2020
Hahn: FDA will make some changes amid COVID-19 permanent
1 June 2020 - The US FDA will look to permanently implement some of the processes and policies adopted in ...
Posted by Michael Wonder on 02 Jun 2020
Novartis provides update on FDA review of ofatumumab, a self-administered, targeted B-cell therapy for patients with relapsing multiple sclerosis
2 June 2020 - Novartis today announced that it has received notice from the US FDA that the agency has extended ...